Compare EXEL & DOGZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | EXEL | DOGZ |
|---|---|---|
| Founded | 1994 | 2003 |
| Country | United States | China |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Miscellaneous manufacturing industries |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 11.1B | 153.5M |
| IPO Year | 2000 | 2017 |
| Metric | EXEL | DOGZ |
|---|---|---|
| Price | $43.49 | $10.60 |
| Analyst Decision | Buy | |
| Analyst Count | 23 | 0 |
| Target Price | ★ $45.18 | N/A |
| AVG Volume (30 Days) | ★ 2.6M | 161.1K |
| Earning Date | 02-10-2026 | 10-17-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 53.55 | N/A |
| EPS | ★ 2.38 | N/A |
| Revenue | ★ $2,288,218,000.00 | $20,707,707.00 |
| Revenue This Year | $9.79 | N/A |
| Revenue Next Year | $12.01 | N/A |
| P/E Ratio | $18.44 | ★ N/A |
| Revenue Growth | 9.93 | ★ 39.47 |
| 52 Week Low | $31.90 | $6.81 |
| 52 Week High | $49.62 | $49.00 |
| Indicator | EXEL | DOGZ |
|---|---|---|
| Relative Strength Index (RSI) | 50.00 | 47.21 |
| Support Level | $40.83 | $10.00 |
| Resistance Level | $47.24 | $10.82 |
| Average True Range (ATR) | 1.10 | 0.47 |
| MACD | -0.07 | 0.10 |
| Stochastic Oscillator | 42.33 | 65.68 |
Exelixis Inc is a biopharmaceutical firm that discovers, develops, and commercializes treatments for cancer. Its molecule, cabozantinib, is indicated for the treatment of patients with metastatic medullary thyroid cancer under the name Cometriq and for the treatment of kidney and liver cancer under the name Cabometyx. Exelixis and its partner Roche have also brought Cotellic to market for the treatment of melanoma.
Dogness (International) Corp designs, manufactures pet products, including leashes and smart products, and lanyards. The company designs, processes, and manufactures fashionable and high-quality leashes, collars, and harnesses to complement cats' and dogs' appearances, as well as intelligent pet products. The company also provides dyeing services to external customers, as well as pet grooming services. The dyeing service is to utilize the existing production capacity and the pet grooming service is immaterial. Geographically, it generates maximum revenue from Mainland China and also has a presence in the United States, Europe, Australia, Canada, Central, and South America, Japan, and other Asian countries and regions.